Metabolon, Inc. We are an emerging technology company developing proprietary analytical methods and software for biomarker discovery using metabolomics. The company conducts a fee-for-service business using metabolomics in pharmaceutical, biotech, agriculture, cosmetic and consumer product research. In addition, the company is using their metabolomics platform to develop diagnostics for cancer, amyotropic lateral sclerosis (ALS, or Lou Gehrig’s disease), and metabolic diseases.